Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironment

27 May 2024

Abstract excerpt

Hepatocellular carcinoma (HCC) represents a major global health threat with diverse and complex pathogenesis. Aldo-keto reductase family 1 member B10 (AKR1B10), a tumor-associated enzyme, exhibits abnormal expression in various cancers. However, a comprehensive understanding of AKR1B10's role in HCC is lacking. This study aims to explore the expression characteristics of AKR1B10 in HCC and its correlation with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aldose Reductase and Taurine
Share to Autophagy in Disease and Therapy
Share to Epigenetics and DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 38802416
DOI: 10.1038/s41598-024-62323-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

AKR1B10 expression characteristics in hepatocellular carcinoma and its correlation with clinicopathological features and immune microenvironmentPMID 38802416Read ↗

AKR1B10 Expression Characteristics in Hepatocellular Carcinoma and Its Correlation with Clinicopathological Features and Immune MicroenvironmentSemantic proximity Read ↗

AKR1B10 inhibits the proliferation and metastasis of hepatocellular carcinoma cells by regulating the PI3K/AKT pathwaySemantic proximity Read ↗

Identification and validation of AKR1C1/2/3 as hepatocellular carcinoma risk modules via an integrated strategySemantic proximity Read ↗

AKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathwaySemantic proximity Read ↗

Comprehensive clinical analysis of AKR1 expression profiles in the diagnosis of human colorectal cancerSemantic proximity Read ↗

AKR1B10 inhibits the proliferation and migration of gastric cancer via regulating epithelial-mesenchymal transitionSemantic proximity Read ↗

LncRNA 1700020I14Rik promotes AKR1B10 expression and activates Erk pathway to induce hepatocyte damage in alcoholic hepatitisSemantic proximity Read ↗

Aldehyde dehydrogenase 1 (ALDH1) isoform expression and potential clinical implications in hepatocellular carcinomaSemantic proximity Read ↗

Genome-Wide and Differential Proteomic Analysis of Hepatitis B Virus and Aflatoxin B1 Related Hepatocellular Carcinoma in Guangxi, ChinaSemantic proximity Read ↗

Integrated analysis of the impact of age on genetic and clinical aspects of hepatocellular carcinoma.Semantic proximity Read ↗

Lipid Metabolism related Gene Expression is correlated with Immune-metabolic Microenvironment and Predicts Prognosis in Hepatocellular CarcinomaSemantic proximity Read ↗

Pretreatment AKR1B10 expression predicts the risk of hepatocellular carcinoma development after hepatitis C virus eradication.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.